PREVENTION OF HYPERURICEMIA IN LEUKEMIA AND LYMPHOMA: USE OF ALOPURINOL, A XANTHINE OXIDASE INHIBITOR.
D000293:Adolescent; D000970:Antineoplastic Agents; D001769:Blood; D001806:Blood Urea Nitrogen; D004358:Drug Therapy; D005853:Geriatrics; D006801:Humans; D033461:Hyperuricemia; D007938:Leukemia; D007951:Leukemia, Myeloid; D008223:Lymphoma; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D008660:Metabolism; D009369:Neoplasms; D009584:Nitrogen; D011743:Pyrimidines; D012509:Sarcoma; D014508:Urea; D014527:Uric Acid; D014528:Uricosuric Agents; D014556:Urine; D014969:Xanthine Oxidase
D000970:Antineoplastic Agents; D011743:Pyrimidines; D014528:Uricosuric Agents; D014527:Uric Acid; D014508:Urea; D014969:Xanthine Oxidase; D009584:Nitrogen
ADOLESCENCE; ANTINEOPLASTIC AGENTS; BLOOD; BLOOD UREA NITROGEN; DRUG THERAPY; GERIATRICS; LEUKEMIA; LEUKEMIA, MYELOCYTIC; LYMPHOSARCOMA; METABOLISM; NITROGEN; PYRIMIDINES; SARCOMA, RETICULUM CELL; UREA; URIC ACID; URICOSURIC AGENTS; URINE; XANTHINE OXIDASE